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   Seven patients with recurrent superficial bladder tumors were treated by vesical and intrader-
mal administration of BCG. All of these patients have had recurrence more than 2 times. BCG 
instillation was performed every weeks for 6 weeks after transurethral resection of bladder tumor. 
A suspension containing 120 mg BCG in 40 ml normal saline was instilled intravesically. BCG was 
administered Into alternate upper thighs using a multiple puncture apparatus. Statistical analysis 
of bladder tumor in our hospital revealed the second recurrence rate to be 73.2%. The reduction 
of tumor recurrence rate of BCG treated patients was 43.0%. The reduction of tumor recurrence 
by BCG treatment was statistically significant, compared to other treatments. It seemed that 
patients with severe side effects such as bladder tenesmus and urinary infection, have a long 
tumor-free period. Therefore, we suggest that the reactive inflammation in bladder during BCG 
treatment plays an important role. 
                                                   (Acta Urol. Jpn. 34: 983--986, 1988)











症 例 は1983年10月よ り1985年3月まで の再 発 性 表 在
性膀 胱腫 瘍 患 者 で男 性5人,女 性2人 で あ る.全 症 例
とも移行 上 皮 癌,Gradelで,再 発 回 数 は1～6回 で
あ った.BCG膀 胱 注入 後 の 観察 期 間 は5～35ヵ 月,
平 均17ヵ月 で あ った(Tablel).
Moralesらの方 法 に 準 じてBCG120mgを 生 食





















8CG諭注前の 平均得範症例 年齢 性

































































































Fig.1.BCG膀胱 注 入 前 の再 発 回数 と治 療
















































が持続し,ま た,皮 内接種部 の発赤,掻 痒感が強く
BCG膀 注を5回 で中止した.症 例2で は肉眼的血尿







中野,ほ か:膀胱腫瘍 ・BCG膀胱内注入療法 985
Table3.副作 用 と治療 効果
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対 してBCG膀 注 を行い再発率42.9%と良好な再発
防止効果を得た.特に再発回数が4回以上の2症例に
再発を防止できたのは,BCG膀 注が有効な治療法で
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